CCDC169-SOHLH2
Basic information
Region (hg38): 13:36168794-36297842
Previous symbols: [ "C13orf38-SOHLH2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCDC169-SOHLH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 3 | 0 | 0 |
Variants in CCDC169-SOHLH2
This is a list of pathogenic ClinVar variants found in the CCDC169-SOHLH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-36170537-G-T | not specified | Uncertain significance (Apr 13, 2022) | ||
13-36170583-C-T | CCDC169-SOHLH2-related disorder | Likely benign (Mar 05, 2019) | ||
13-36170584-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
13-36170653-C-G | not specified | Uncertain significance (Jan 16, 2024) | ||
13-36170662-C-T | not specified | Uncertain significance (May 25, 2022) | ||
13-36170663-G-A | CCDC169-SOHLH2-related disorder | Benign (Nov 08, 2019) | ||
13-36170721-G-A | not specified | Uncertain significance (May 24, 2023) | ||
13-36170721-G-C | not specified | Uncertain significance (Dec 06, 2021) | ||
13-36170739-G-C | not specified | Uncertain significance (Mar 07, 2024) | ||
13-36170769-G-A | not specified | Uncertain significance (Mar 23, 2022) | ||
13-36170773-C-T | SOHLH2-related disorder | Benign (Oct 25, 2019) | ||
13-36170783-T-C | SOHLH2-related disorder | Likely benign (Mar 01, 2019) | ||
13-36173727-G-A | not specified | Uncertain significance (May 30, 2023) | ||
13-36173749-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
13-36173751-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
13-36173782-G-A | not specified | Uncertain significance (Feb 17, 2022) | ||
13-36173786-G-A | SOHLH2-related disorder | Likely benign (Mar 12, 2019) | ||
13-36174733-C-T | not specified | Likely benign (Aug 09, 2021) | ||
13-36174820-C-T | SOHLH2-related disorder | Likely benign (Jul 11, 2023) | ||
13-36174835-T-A | not specified | Uncertain significance (Jun 12, 2023) | ||
13-36189977-G-A | not specified | Uncertain significance (Nov 01, 2024) | ||
13-36189990-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
13-36189998-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
13-36190036-C-T | not specified | Likely benign (Apr 08, 2022) | ||
13-36191833-G-A | SOHLH2-related disorder | Benign (Oct 07, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCDC169-SOHLH2 | protein_coding | protein_coding | ENST00000511166 | 15 | 129049 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00124 | 0.998 | 125731 | 0 | 13 | 125744 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.03 | 212 | 259 | 0.820 | 0.0000132 | 3249 |
Missense in Polyphen | 44 | 63.531 | 0.69257 | 868 | ||
Synonymous | 0.219 | 97 | 99.8 | 0.972 | 0.00000563 | 945 |
Loss of Function | 3.12 | 10 | 27.8 | 0.360 | 0.00000126 | 381 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.0000445 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000145 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription regulator of both male and female germline differentiation. Suppresses genes involved in spermatogonial stem cells maintenance, and induces genes important for spermatogonial differentiation. Coordinates oocyte differentiation without affecting meiosis I (By similarity). {ECO:0000250|UniProtKB:Q6IUP1, ECO:0000250|UniProtKB:Q9D489}.;
Intolerance Scores
- loftool
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.55
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |